Health sciences and the pharmaceutical industry: partnerships can be effective and ethical

Guyatt, Gordon
November 1994
CMAJ: Canadian Medical Association Journal;11/1/1994, Vol. 151 Issue 9, p1323
Academic Journal
No abstract available.


Related Articles

  • New UK guidance on industry-health professional collaboration. Mintzes, Barbara // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;7/7/2012, Vol. 345 Issue 7864, p10 

    The article discusses the new guidance from the Ethical Standards in Health and Life Sciences Group (ESHLSG), which represents professional, representative and regulatory groups from health professional community and pharmaceutical industry. The guidance advocates a role for the drug industry in...

  • Why Aren't More Pediatric Trials Performed? Barrett, Jane // Applied Clinical Trials;Jul2002, Vol. 11 Issue 7, p36 

    Explores the ethical, legal and practical obstacles to pediatric trials. Importance of partnership between pharmaceutical industry, investigators, ethics committees and parents to success of pediatric research; Age-appropriate formulas; Issues of consent. INSET: Can FDA Require Pediatric Studies?.

  • The need for private?public partnerships.  // Nature Medicine;May2000, Vol. 6 Issue 5, p481 

    Editorial. Focuses on the need for private-public partnerships to promote the dissemination of biomedical research discoveries and improve public health. U.S. National Institutes of Health's collaboration with the pharmaceutical industry; Role of the World Health Organization to the...

  • The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES). Bruyere, O.; Kanis, J. A.; Ibar-Abadie, M.-E.; Alsayed, N.; Brandi, M. L.; Burlet, N.; Cahall, D. L.; Chines, A.; Devogelaer, J.-P.; Dere, W.; Goel, N.; Hughes, N.; Kaufman, J.-M.; Korte, S.; Mitlak, B. H.; Niese, D.; Rizzoli, R.; Rovati, L. C.; Reginster, J.-Y. // Osteoporosis International;May2010, Vol. 21 Issue 5, p713 

    This paper provides recommendations for fair and unbiased relationship between academic scientists and the pharmaceutical industry. Real or perceived problems in the relationship between academics and the industry have been the subject of much recent debate. It has been suggested that academic...

  • The Nation Needs a Comprehensive Pharmaceutical Engineering Education and Research System. Hussain, Ajaz // Pharmaceutical Technology;Sep2005, Vol. 29 Issue 9, p122 

    Focuses on the efficiency and effectiveness of the pharmaceutical quality decision-making system to address the increasing complexity of pharmaceutical systems in the U.S. Importance of the pharmaceutical science education system to meet the public health objectives in the country; Means of...

  • The Sunshine Act: Not a good guy versus bad guy issue. Goldenberg, S. Larry // Canadian Urological Association Journal;jan/fev2014, Vol. 8 Issue 1/2, p18 

    The author explores his views on the regulations regarding physician-pharmaceutical industry relations such as Sunshine laws in the U.S., and the University Policies on Conflict of Interest and the Medical Association Codes of Ethics in Canada, which ensure that physicians should focus on...

  • DoH and industry to share cost of drugs.  // GP: General Practitioner;4/8/2002, p8 

    Reports the partnership between the Department of Health and the pharmaceutical industry in funding research on drugs and disease processes in Great Britain.

  • Critical Role of Leadership on Ethical Climate and Salesperson Behaviors. Mulki, Jay; Jaramillo, Jorge; Locander, William // Journal of Business Ethics;May2009, Vol. 86 Issue 2, p125 

    Leaders play a critical role in setting the tone for ethical climate in organizations. In recent years, there has been an increased skepticism about the role played by corporate executives in developing and implementing ethics in business practices. Sales and marketing practices of businesses,...

  • Science-based health innovation in Uganda: creative strategies for applying research to development. Kamunyori, Sheila; Al-Bader, Sara; Sewankambo, Nelson; Singer, Peter A.; Daar, Abdallah S. // BMC International Health & Human Rights;Jan2010 Supplement 1, Vol. 10, p1 

    Background: Uganda has a long history of health research, but still faces critical health problems. It has made a number of recent moves towards building science and technology capacity which could have an impact on local health, if innovation can be fostered and harnessed. Methods: Qualitative...

  • New partnership will create opportunities.  // Chain Drug Review;10/22/2012, Vol. 34 Issue 18, p80 

    The article forecasts the effect of partnership between Walgreen Co. and Alliance Boots GmbH on the pharmaceutical industry around the world.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics